Furthermore, they found that enzyme longevity assurance homologue 2 (LASS2) in association with the transferrin receptor (TFRC) could suppress metastasis in thyroid cancer by regulating ferroptosis, a critical pathway involved in tumor growth and proliferation [93]. Here, TFRC is linked to neoplasm.